Therapeutic management of patent ductus arteriosus

Early Human Development

Volumn 85, Issue 3, 2009, Pages 151-155

  Chiruvolu, Arpitha ^a   Jaleel, Mambarath A ^b  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Chronic lung disease; Ibuprofen lysine; Indomethacin; Intraventricular hemorrhage; Neurodevelopmental impairment; Patent ductus arteriosus

Indexed keywords

DUCTUS ARTERIOSUS, PATENT; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; PRACTICE GUIDELINES AS TOPIC;

EID: 60849096932     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2008.12.007     Document Type: Article

References (43)

1. Koch J., Hensley G., Roy L., Brown S., Ramaciotti C., and Rosenfeld C.R. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 117 4 (2006) 1113-1121
2. Rojas M.A., Gonzalez A., Bancalari E., Claure N., Poole C., and Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 126 4 (1995) 605-610
3. Brown E.R. Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. J Pediatr 95 5 Pt 2 (1979) 865-866
4. Van Overmeire B., and Chemtob S. The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonatal Med 10 2 (2005) 177-184
5. Watterberg K.L., Gerdes J.S., Cole C.H., Aucott S.W., Thilo E.H., Mammel M.C., et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 114 6 (2004) 1649-1657
6. Heymann M.A., Rudolph A.M., and Silverman N.H. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Eng J Med 295 10 (1976) 530-533
7. Knight D.B. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol 6 1 (2001) 63-73
8. Bandstra E.S., Montalvo B.M., Goldberg R.N., Pacheco I., Ferrer P.L., Flynn J., et al. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics 82 4 (1988) 533-542
9. Bada H.S., Green R.S., Pourcyrous M., Leffler C.W., Korones S.B., Magill H.L., et al. Indomethacin reduces the risks of severe intraventricular hemorrhage. J Pediatr 115 4 (1989) 631-637
10. Ment L.R., Ph W., Ehrenkranz R.A., Philip A.G., Vohr B., Allan W., et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 93 4 (1994) 543-550
11. Ment L.R., Vohr B., Oh W., Scott D.T., Allan W.C., Westerveld M., et al. Neurodevelopmental outcome at 36 months' corrected age of preterm infants in the Multicenter Indomethacin Intraventricular Hemorrhage Prevention Trial. Pediatrics 98 4 Pt 1 (1996) 714-718
12. Ment L.R., Vohr B., Allan W., Wesrerweld M., Sparrow S.S., Schneider K.C., et al. Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 105 3 Pt 1 (2000) 485-491
13. Vohr B.R., Allan W.C., Westerveld M., Schneider K.C., Katz K.H., Makuch R.W., et al. School-age outcomes of very low birth weight infants in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 111 4 Pt 1 (2003) e340-6
14. Schmidt B., Davis P., Moddemann D., Ohlsson A., Roberts R.S., Saigal S., et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Eng J Med 344 26 (2001) 1966-1972
15. Schmidt B., Roberts R.S., Fanaroff A., Davis P., Kirpalani H.M., Nwaesei C., et al. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J Pediatr 148 6 (2006) 730-734
16. Fowlie P.W., and Davis P.G. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane database Syst Rev (Online) 3 (2002) CD000174
17. Van Overmeire B., Allegaert K., Casaer A., Debauche C., Decaluwe W., Jespers A., et al. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 364 9449 (2004) 1945-1949
18. Cooke L., Steer P., and Woodgate P. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev (Online) 2 (2003) CD003745
19. Mahony L., Carnero V., Brett C., Heymann M.A., and Clyman R.I. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. N Eng J Med 306 9 (1982) 506-510
20. Van Overmeire B., Van de Broek H., Van Laer P., Weyler J., and Vanhaesebrouck P. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr 138 2 (2001) 205-211
21. Hermes-DeSantis E.R., and Clyman R.I. Patent ductus arteriosus: pathophysiology and management. J Perinatol 26 Suppl 1 (2006) S14-S18 discussion S22-3
22. Kabra N.S., Schmidt B., Roberts R.S., Doyle L.W., Papile L., and Fanaroff A. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 150 3 (2007) 229-234 34 e1
23. Archer N. Patent ductus arteriosus in the newborn. Arch Dis Child 69 5 Spec No (1993) 529-532
24. Bell E.F., Warburton D., Stonestreet B.S., and Oh W. Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants. N Eng J Med 302 11 (1980) 598-604
25. Brion L.P., and Campbell D.E. Furosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants. Cochrane Database Syst Rev (Online) 3 (2001) CD001148
26. Hammerman C., and Kaplan M. Patent ductus arteriousus in the premature neonate: current concepts in pharmacological management. Paediatr drugs 1 2 (1999) 81-92
27. Gersony W.M., Peckham G.J., Ellison R.C., Miettinen O.S., and Nadas A.S. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 102 6 (1983) 895-906
28. Narayanan M., Cooper B., Weiss H., and Clyman R.I. Prophylactic indomethacin: factors determining permanent ductus arteriosus closure. J Pediatr 136 3 (2000) 330-337
29. Ramsay J.M., Murphy Jr. D.J., Vick III G.W., Courtney J.T., Garcia-Prats J.A., and Huhta J.C. Response of the patent ductus arteriosus to indomethacin treatment. Am J Dis Child 141 3 (1987) 294-297
30. Van Overmeire B., Smets K., Lecoutere D., Van de Broek H., Weyler J., and Degroote K. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Eng J Med 343 10 (2000) 674-681
31. Thomas R.L., Parker G.C., Van Overmeire B., and Aranda J.V. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 164 3 (2005) 135-140
32. Ohlsson A., Walia R., and Shah S. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev (Online) 2 (2003) CD003481
33. Herrera C., Holberton J., and Davis P. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev (Online) 2 (2007) CD003480
34. Hines M.H., Raines K.H., Payne R.M., Covitz W., Cnota J.F., Smith T.E., et al. Video-assisted ductal ligation in premature infants. Ann Thorac Surg 76 5 (2003) 1417-1420 Nov discussion 20
35. Palder S.B., Schwartz M.Z., Tyson K.R., and Marr C.C. Management of patent ductus arteriosus: a comparison of operative v pharmacologic treatment. J Pediatr Surg 22 12 (1987) 1171-1174
36. Trus T., Winthrop A.L., Pipe S., Shah J., Langer J.C., and Lau G.Y. Optimal management of patent ductus arteriosus in the neonate weighing less than 800 g. J Pediatr Surg 28 9 (1993) 1137-1139
37. Malviya M., Ohlsson A., and Shah S. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev (Online) 1 (2008) CD003951
38. Wagner H.R., Ellison R.C., Zierler S., Lang P., Purohit D.M., and Behrendt D. Surgical closure of patent ductus arteriosus in 268 preterm infants. J Thorac Cardiovasc Surg 87 6 (1984) 870-875 Jun
39. Eggert L.D., Jung A.J., EC M.C., and Ruttenberg H.D. Surgical treatment of patent ductus arteriosus in preterm infants. Four-year experience with ligation in the newborn intensive care unit. Pediatr Cardiol 2 1 (1982) 15-18
40. Fan L.L., Campbell D.N., Clarke D.R., Washington R.L., Fix E.J., and White C.W. Paralyzed left vocal cord associated with ligation of patent ductus arteriosus. J Thorac Cardiovasc Surg 98 4 (1989) 611-613
41. Stempniewicz K., and Walas W. Chylothorax-a rare complication of surgical ligation of patent ductus arteriosus in a premature infant-a case report. Med Wieku Rozwoj 11 3 Pt 1 (2007) 269-273
42. Robie D.K., Waltrip T., Garcia-Prats J.A., Pokorny W.J., and Jaksic T. Is surgical ligation of a patent ductus arteriosus the preferred initial approach for the neonate with extremely low birth weight?. J Pediatr Surg 31 8 (1996) 1134-1137
43. Lee J., Rajadurai V.S., Tan K.W., Wong K.Y., Wong E.H., and Leong J.Y. Randomized trial of prolonged low-dose versus conventional-dose indomethacin for treating patent ductus arteriosus in very low birth weight infants. Pediatrics 112 2 (2003) 345-350